Genome-wide interrogation of longitudinal FEV₁in children with asthma

Keyphrases

• Forced Expiratory Volume in 1 Second (FEV1) 100%
• Children with Asthma 100%
• Lung Function 66%
• Placebo 66%
• Single nucleotide Polymorphism 66%
• Nedocromil 66%
• Longitudinal Traits 66%
• Childhood Asthma Management Program 66%
• Gene Expression 33%
• Genetic Determinants 33%
• Genome-wide Association Study 33%
• Potential Treatments 33%
• Lung Function Decline 33%
• Asthma 33%
• Population-based 33%
• Chronic Disease 33%
• Targeted Treatment 33%
• Genetic Mapping 33%
• Presence-absence 33%
• NONMEM 33%
• Chromatin Immunoprecipitation (ChIP) 33%
• Phenotypic Data 33%
• Human Lung Tissue 33%
• Progression Model 33%
• False Discovery Rate 33%
• Human Lung Fibroblasts 33%
• Lung Fibroblasts 33%
• RNA-seq Data 33%
• Budesonide 33%
• Disease Pathophysiology 33%
• Enhancer Region 33%
• Strong Enhancer 33%
• Dynamic Progress 33%
• Single Time Point 33%
• Longitudinal Progression 33%
• Exponential Structure 33%

Biochemistry, Genetics and Molecular Biology

• Genetics 100%
• Single-Nucleotide Polymorphism 100%
• Enhancer Region 100%
• Fibroblast 100%
• RNA Sequencing 50%
• Gene Expression 50%
• Genome-Wide Association Study 50%
• Gene Mapping 50%
• Budesonide 50%

Immunology and Microbiology

• Asthma 100%
• Nedocromil 33%
• Single Nucleotide Polymorphism 33%
• Enhancer Region 33%
• Lung Fibroblast 33%
• RNA Sequencing 16%
• Gene Expression 16%
• Genome-Wide Association Study 16%
• Gene Mapping 16%
• Budesonide 16%
• Replication 16%